跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,590 条关于
“HRD”
全部
2,590
临床试验
1,843
药物
418
机构
12
资讯
317
去年
Niraparib Shows Promise in Extending Progression-Free Survival in Epithelial Ovarian Cancer
12天前
AcroMeta to Enter Ambient Temperature Cellular Logistics Through Strategic Partnership with Macro HRD
去年
PD-L1 Expression Correlates with HRD Status and Predicts Survival in High-Grade Serous Ovarian Cancer
去年
Eisbach Bio Relocates to Houston with $4.75M CPRIT Grant to Advance EIS-12656 Trial in HRD Tumors
去年
Targeting Effector Regulatory T Cells Enhances PARP Inhibitor Therapy in Ovarian Cancer
2个月前
AI-Derived Biomarker From Routine Pathology Images Predicts Individual Benefit From PARP Inhibitors in Ovarian Cancer
8个月前
Whole-Genome Sequencing Algorithm Outperforms Standard Tests for Predicting PARP Inhibitor Response
4个月前
MammaPrint Genomic Profiling Predicts Anthracycline Benefit in HR+HER2- Early Breast Cancer, Guiding NCCN Guideline Update
去年
Duke Street Bio Receives EMA Approval for First-in-Human Trial of PARP1 Inhibitor DSB2455
11个月前
Long-Term Survival Data Reinforce PARP Inhibitor Benefits in BRCA-Mutated Ovarian Cancer
第 1 页,共 32 页
上一页
下一页